These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 24686338)

  • 1. Inferring speaker attributes in adductor spasmodic dysphonia: ratings from unfamiliar listeners.
    Isetti D; Xuereb L; Eadie TL
    Am J Speech Lang Pathol; 2014 May; 23(2):134-45. PubMed ID: 24686338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of experience on judgments of adductor spasmodic dysphonia.
    Eadie TL; Nicolici C; Baylor C; Almand K; Waugh P; Maronian N
    Ann Otol Rhinol Laryngol; 2007 Sep; 116(9):695-701. PubMed ID: 17926593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Information and Severity on Perception of Speakers With Adductor Spasmodic Dysphonia.
    Eadie TL; Rajabzadeh R; Isetti DD; Nevdahl MT; Baylor CR
    Am J Speech Lang Pathol; 2017 May; 26(2):327-341. PubMed ID: 28249075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everyday listeners' impressions of speech produced by individuals with adductor spasmodic dysphonia.
    Nagle KF; Eadie TL; Yorkston KM
    J Commun Disord; 2015; 58():1-13. PubMed ID: 26209746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of experience on judgments of dysphonia.
    Eadie TL; Kapsner M; Rosenzweig J; Waugh P; Hillel A; Merati A
    J Voice; 2010 Sep; 24(5):564-73. PubMed ID: 19765949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphonia.
    Yeung JC; Fung K; Davis E; Rai SK; Day AM; Dzioba A; Bornbaum C; Doyle PC
    Laryngoscope; 2015 Mar; 125(3):661-6. PubMed ID: 25290557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of consonant voicing characteristics on sentence production in abductor versus adductor spasmodic dysphonia.
    Cannito MP; Chorna LB; Kahane JC; Dworkin JP
    J Voice; 2014 May; 28(3):394.e13-22. PubMed ID: 24440058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated acoustic analysis of task dependency in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N; Mazin A; Awan SN
    Laryngoscope; 2014 Mar; 124(3):718-24. PubMed ID: 23946147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptual structure of adductor spasmodic dysphonia and its acoustic correlates.
    Cannito MP; Doiuchi M; Murry T; Woodson GE
    J Voice; 2012 Nov; 26(6):818.e5-13. PubMed ID: 23177751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech intelligibility in severe adductor spasmodic dysphonia.
    Bender BK; Cannito MP; Murry T; Woodson GE
    J Speech Lang Hear Res; 2004 Feb; 47(1):21-32. PubMed ID: 15072525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior Assessment Battery: A Pilot Study of the Affective, Behavioral, and Cognitive Correlates Surrounding Spasmodic Dysphonia.
    Vanryckeghem M; Hoffman Ruddy B; Lehman J
    J Voice; 2016 Jan; 30(1):53-60. PubMed ID: 26209041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the OMNI vocal effort scale in the treatment of adductor spasmodic dysphonia.
    Shoffel-Havakuk H; Marks KL; Morton M; Johns MM; Hapner ER
    Laryngoscope; 2019 Feb; 129(2):448-453. PubMed ID: 30315575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of listener experience and anchors on judgments of dysphonia.
    Eadie TL; Kapsner-Smith M
    J Speech Lang Hear Res; 2011 Apr; 54(2):430-47. PubMed ID: 20884782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.
    Braden MN; Johns MM; Klein AM; Delgaudio JM; Gilman M; Hapner ER
    J Voice; 2010 Mar; 24(2):242-9. PubMed ID: 19481417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N; Gouse M; Mauszycki SC; Merrill RM; Smith ME
    Laryngoscope; 2005 Feb; 115(2):311-6. PubMed ID: 15689757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical versus laboratory ratings of voice using the CAPE-V.
    Solomon NP; Helou LB; Stojadinovic A
    J Voice; 2011 Jan; 25(1):e7-14. PubMed ID: 20430573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Top-down mechanisms in dysphonia perception: the need for blind tests.
    Ghio A; Révis J; Merienne S; Giovanni A
    J Voice; 2013 Jul; 27(4):481-5. PubMed ID: 23809570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Dysphonia and Cognitive-Perceptual Listener Strategies on Speech Intelligibility.
    Porcaro CK; Evitts PM; King N; Hood C; Campbell E; White L; Veraguas J
    J Voice; 2020 Sep; 34(5):806.e7-806.e18. PubMed ID: 31031103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.